KINGS.PA - eureKING société anonyme
| Previous close | 10.30 |
| Open | 10.30 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 10.30 - 10.30 |
| 52-week range | 9.70 - 10.30 |
| Volume | |
| Avg. volume | 160 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
eureKING Announces the Publication of Its Financial Results for the Period From April 1 to September 30, 2022
PARIS, December 30, 2022--Regulatory News: eureKING (mnemonic: KINGS - ISIN: FR0014009ON9), the French SPAC dedicated to healthcare and more specifically to biomanufacturing in Europe, announced today the publication of its financial results for the period from April 1 to September 30, 2022, approved by the Board of Directors on December 12th, 2022.
Business WireSPAC eureKING Obtains the TIBI label and Strengthens Its Status as a Prime Investor for the Creation of a Major Biomanufacturing Player in Europe
PARIS, September 13, 2022--Regulatory News: eureKING (mnemonic: KINGS – ISIN: FR0014009ON9) (Paris:KINGS), the French SPAC dedicated to healthcare and more specifically to biomanufacturing in Europe, officially announces the successful attainment of the TIBI label. The French Government’s initiative allows labeled technology companies to access an initially €6 billion investment fund, valued today at more than €18 billion, comprised of 21 leading French institutional investors.